Meiji to Sell JV Stake to Dong-A, but Will Continue Biosimilar Collaboration

July 28, 2021
Meiji Seika Pharma said on July 27 that it has entered into an agreement to sell the entire 49% stake it has in a joint venture with Dong-A Socio Holdings to the South Korean partner for an undisclosed sum. The...read more